Plasma phencyclidine pharmacokinetics in dog and monkey using a gas chromatography selected ion monitoring assay
dc.contributor.author | Wilson, A. E. | |
dc.contributor.author | Domino, E. F. | |
dc.date.accessioned | 2018-07-13T15:47:20Z | |
dc.date.available | 2018-07-13T15:47:20Z | |
dc.date.issued | 1978-02 | |
dc.identifier.citation | Wilson, A. E.; Domino, E. F. (1978). "Plasma phencyclidine pharmacokinetics in dog and monkey using a gas chromatography selected ion monitoring assay." Biomedical Mass Spectrometry 5(2): 112-116. | |
dc.identifier.issn | 0306-042X | |
dc.identifier.issn | 1096-9888 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/144632 | |
dc.description.abstract | Phencyclidine was determined by gas chromatography selected ion monitoring in six dogs and seven monkeys. Aliquots of venous blood were taken over 4 h in the monkey after 1.1 mg kg−1 and over 24 h in the dog after 1.0 mg kg−1 of phencyclidine i.v. Pentadeuterated phencyclidine was used as the internal standard. In the electron impact mode the most abundant fragments in the mass spectrum of phencyclidine were m/e 91 and 200, and 96 and 205 in the [2H5]phencyclidine spectrum. These fragments were used to quantitate the amount of phencyclidine present. In both species, a complex exponential decline of plasma phencyclidine was found in most animals that fit a two compartment open model. In monkey, the mean half‐life (β phase) was 2.36 h and in the dog it was 2.86 h. Compared with the monkey, the dog exhibited considerable emergence delirium. The two species had rather different pharmacokinetics which may be relevant to the observed differences in degree of anesthesia and recovery. | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | |
dc.title | Plasma phencyclidine pharmacokinetics in dog and monkey using a gas chromatography selected ion monitoring assay | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Biomedical Engineering | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.subject.hlbtoplevel | Engineering | |
dc.description.peerreviewed | Peer Reviewed | |
dc.contributor.affiliationum | Department of Pharmacology, The University of Michigan, Ann Arbor, Michigan 48109, USA | |
dc.contributor.affiliationother | Lafayette Clinic, Detroit, Michigan 48207, USA | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/144632/1/bms1200050203.pdf | |
dc.identifier.doi | 10.1002/bms.1200050203 | |
dc.identifier.source | Biomedical Mass Spectrometry | |
dc.identifier.citedreference | G. F. Kessler, J. Demers, C. Berlin and R. W. Brennan, N. Engl. J. Med. ( 1974 ) 291, 979. | |
dc.identifier.citedreference | J. M. Rainey and M. K. Crowder, J. Am. Med. Assoc. 230 (Lett.) 824 ( 1974 ). | |
dc.identifier.citedreference | J. W. Eastmann and S. N. Cohen J. Am. Med. Assoc. 231, 1270 ( 1975 ). | |
dc.identifier.citedreference | R. C. Gupta, I. Liu, G.‐L. Oei and G. D. Lundberg, Clin. Toxicol. 8, 611 ( 1975 ). | |
dc.identifier.citedreference | P. C. Reynolds, Clin. Toxicol. 9, 547 ( 1976 ). | |
dc.identifier.citedreference | R. E. Ober, G. W. Gwynn, T. Chang, D. A. McCarthy and A. J. Glazko, Fed. Proc. Fed. Am. Soc. Exp. Biol. 22, 539 ( 1963 ). | |
dc.identifier.citedreference | A. J. Glazko, Antimicrob, Agents and Chemother. 3, 660 ( 1966 ). | |
dc.identifier.citedreference | J. E. Lindgren, C. G. Hammar, R. Heisling and B. Holmstedt, Am. J. Pharm. 141, 86 ( 1969 ). | |
dc.identifier.citedreference | C. G. Hammar, B. Holmstedt, J. E. Lindgren and R. Tham, Adv. Pharmacol. Chemother. 7, 53 ( 1969 ). | |
dc.identifier.citedreference | N. C. Law, V. Aandahl, H. M. Faber and W. A. Milne, Clin. Chim. Acta 32, 221 ( 1971 ). | |
dc.identifier.citedreference | L. K. Wong and D. Biemann, Clin. Toxicol. 9, 583 ( 1976 ). | |
dc.identifier.citedreference | D. C. K. Lin, A. F. Fentiman, R. L. Foltz, R. D. Forney and I. Sunshine, Biomed. Mass Spectrom. 2, 206 ( 1975 ). | |
dc.identifier.citedreference | W. D. McLeod, D. E. Green and E. Seet, Clin. Toxicol. 9, 561 ( 1976 ). | |
dc.identifier.citedreference | J. A. Marshman, M. P. Ramsey and E. M. Sellers, Toxicol. Appl. Pharmacol. 35, 129 ( 1976 ). | |
dc.identifier.citedreference | J. G. Wagner, E. Novak, L. G. Leslie and C. M. Metzler Int. J. Clin. Pharmacol. 1, 261 ( 1968 ). | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.